Liraglutide is a well-established GLP-1 medication that supports gradual and sustained weight loss when combined with healthy diet and exercise
Fatigue and headache, especially during the adjustment phase
GLP-1-related acid reflux is being massively under-reported
Certain foods, such as those with a high glycemic index or dairy products, may affect acne in some people
Unlike other medications, Retatrutide acts as a "triple G" agonist, targeting GLP-1, GIP, and GCG receptors, which helps reduce hunger and promote weight loss
The patent clarifies that compositions of the product duo improved skin and impacted key regulatory genes that are associated with several important cellular pathways